Quashing Drug Prosecutions for (i) Limitation Bar and (ii) Defeat of Section 25(3) Right Due to Delay
1. Introduction
This petition challenged a criminal complaint under the Drugs and Cosmetics Act, 1940 alleging contraventions of
Section 18(a)(i) and Section 18(B) read with Section 27(d).
The complaint arose after a routine inspection on 09.01.2014 at the premises of M/S JAF (accused No.1),
where samples including “CADCAL capsules (4x5x10 caps)” (manufactured by the petitioner) were lifted and sent for analysis.
The key issues were:
-
Whether cognizance taken in April 2018 was barred by limitation under Section 538-B of the J&K Cr. P. C.
-
Whether delay in intimation/filing complaint defeated the petitioner’s statutory right under Section 25(3) of the Act
to controvert the Government Analyst’s report (by seeking re-testing), warranting quashing.
The petitioner (manufacturer) sought quashing of the complaint and consequential proceedings insofar as it was concerned.
2. Summary of the Judgment
The High Court quashed the complaint and proceedings to the extent of the petitioner on two independent grounds:
-
Limitation: The complaint was filed beyond the permissible limitation period (three years),
and neither the complaint explained the delay nor did the Magistrate record reasons to condone it under Section 538-G.
-
Section 25(3) prejudice: Inaction and delay by the Drugs Inspector resulted in the sample expiring before the petitioner
could meaningfully exercise the right to controvert the Government Analyst’s report, causing serious prejudice and rendering continuation
of prosecution an abuse of process.
3. Analysis
3.1 Precedents Cited (and their influence)
Municipal Corporation of vs. Ghisa Ram, AIR 1967 SC 970
The Court relied on the principle that where a statute confers a valuable defence right to obtain a superior/central laboratory test,
the prosecution must proceed with reasonable dispatch so the right is not rendered illusory. In Ghisa Ram, denial of that right due to
prosecution conduct was treated as causing serious prejudice, making it improper to sustain conviction based on the analyst report alone.
Influence here: It supplied the foundational fairness principle—procedural delay that defeats a statutory retest right is prejudicial.
The Rajasthan High Court emphasized that expiry/shelf-life of the sample is critical and complaints must be filed expeditiously so
the accused does not lose the ability to seek central laboratory analysis.
Influence here: Reinforced that speed is not merely administrative; it protects a statutory defence.
The Punjab & Haryana High Court quashed proceedings where the Drugs Inspector’s lapse resulted in the sample being sent only after expiry,
thereby depriving the accused of the right under Section 25(3).
Influence here: Provided a closely analogous Drugs and Cosmetics Act scenario supporting quashing as the appropriate remedy.
State of Haryana v. Unique Farmaid (P) Ltd., (1999) 8 SCC 190
Though arising under the Insecticides Act, the Supreme Court treated the retesting provision as analogous and held that once the shelf life expires,
the accused’s right to seek central lab testing becomes ineffective; continuing prosecution would be an abuse of process.
Influence here: Anchored the proposition that loss of retest right due to delay can justify quashing at the threshold.
The Supreme Court quashed proceedings where the accused was deprived of rights under Section 25(3) and 25(4) due to delay.
Influence here: Operated as direct Supreme Court authority in the Drugs Act context confirming that defeat of Section 25 rights is fatal to prosecution.
3.2 Legal Reasoning
(A) Limitation bar under Section 538-B of the J&K Cr. P. C
-
The offences alleged were punishable up to two years (Section 27(d)), placing them within the
three-year limitation category under Section 538-B(2).
-
The Court treated limitation as commencing when the Drugs Inspector received the Government Analyst report, i.e., 11.11.2014
(as pleaded in the complaint).
-
The complaint was filed on 16.04.2018, i.e., after more than three years.
-
While Section 538-G permits cognizance beyond limitation if delay is explained or required in the interest of justice,
the complaint contained no explanation, and the Magistrate recorded no reasons for condonation.
Result: Cognizance and process order dated 17.04.2018 was held legally unsustainable.
(B) Defeat of the statutory right under Section 25(3) of the Act
-
Section 25(3) makes the Government Analyst’s report conclusive unless, within 28 days of receiving it, the concerned person notifies
intent to adduce evidence to controvert it (practically by seeking court-facilitated retesting).
-
The Court found that delay in informing the petitioner and inordinate delay in filing the complaint meant that by the time
proceedings were initiated, the drug had already expired, making retesting ineffective and thereby neutralizing the defence right.
-
Applying the cited precedents, the Court treated this as serious prejudice attributable to the Inspector’s inaction/negligence,
warranting quashing.
Note on dates in the judgment text: The complaint narrative states expiry as 04/2015, while paragraph 13 mentions
April 2014. The Court’s operative reasoning proceeds on the practical conclusion that the sample had expired before the petitioner could effectively exercise Section 25(3) and certainly long before the complaint was filed in April 2018.
3.3 Impact
-
Stricter discipline on limitation: Prosecuting agencies in J&K must ensure complaints under the Drugs and Cosmetics Act are filed within
the limitation window counted from receipt/knowledge of the analyst report, or else plead and justify delay and obtain a reasoned condonation under
Section 538-G.
-
Operationalizing Section 25(3): Inspectors must act with “reasonable dispatch” so that the statutory retest/controversion right remains real.
Delays that allow the sample/drug to expire can render proceedings vulnerable to quashing.
-
Defence strategy: Manufacturers and supply-chain entities can challenge prosecutions on two tracks—(i) limitation and (ii) loss of retest right—
particularly where the record shows delayed analyst communication or delayed filing after shelf-life expiry.
-
Case management by Magistrates: Orders taking cognizance beyond limitation must reflect conscious exercise of power with recorded reasons,
else they risk being set aside.
4. Complex Concepts Simplified
-
Cognizance: The stage when a criminal court formally takes notice of an alleged offence and decides to proceed (e.g., by issuing process).
-
Limitation (criminal): A statutory time limit within which a court may take cognizance. After it expires, the court ordinarily cannot proceed,
unless the law permits condonation with reasons.
-
Section 25(3) right (Drugs Act): A statutory opportunity to challenge (“controvert”) the Government Analyst’s report within a defined time.
If not exercised—or if made impossible by prosecutorial delay—the analyst report may unfairly become the decisive evidence.
-
Shelf life/expiry relevance: If the sample/drug expires, retesting may no longer be scientifically reliable or legally meaningful, effectively
destroying the accused’s ability to challenge the initial report.
-
Abuse of process: Continuing a prosecution that is procedurally unfair (e.g., time-barred or denying a statutory defence right) is treated as
misuse of the criminal process warranting quashing.
5. Conclusion
The judgment establishes that prosecutions under the Drugs and Cosmetics Act in J&K are vulnerable to quashing where:
(i) the complaint is filed beyond the three-year limitation applicable to offences punishable up to two years and the delay is neither explained nor
condoned by a reasoned order under Section 538-G; and independently,
(ii) prosecutorial/inspector delay defeats the accused’s valuable statutory right under Section 25(3) to controvert the Government Analyst’s report,
especially when expiry renders retesting impracticable.
By quashing proceedings (to the petitioner’s extent), the Court reinforces procedural rigor as an integral part of substantive fairness in drug-quality prosecutions.